{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:28:12Z","timestamp":1769041692569,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04487-2","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:51:23Z","timestamp":1768989083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hormonal and metabolic profiles in teenagers and young adults with polycystic ovary syndrome (PCOS)"],"prefix":"10.1007","volume":"91","author":[{"given":"Anna","family":"Bareja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianna","family":"Adamczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Seman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Kacalska-Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Jach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Pir\u00f3g","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"10","key":"4487_CR1","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"H.J. Teede et al., Recommendations from the 2023 international Evidence-based guideline for the assessment and management of polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 108(10), 2447\u20132469 (2023)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"4487_CR2","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"H.J. Teede et al., Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. 33(9), 1602\u20131618 (2018)","journal-title":"Hum. Reprod."},{"issue":"1","key":"4487_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12902-024-01733-y","volume":"24","author":"A Mansour","year":"2024","unstructured":"A. Mansour et al., Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome. BMC Endocr. Disord. 24(1), 201 (2024)","journal-title":"BMC Endocr. Disord"},{"issue":"1","key":"4487_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"RE Group","year":"2004","unstructured":"R.E. Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81(1), 19\u201325 (2004)","journal-title":"Fertil. Steril."},{"key":"4487_CR5","doi-asserted-by":"publisher","first-page":"1085656","DOI":"10.3389\/fendo.2022.1085656","volume":"13","author":"H Zhang","year":"2022","unstructured":"H. Zhang et al., Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Front. Endocrinol. (Lausanne). 13, 1085656 (2022)","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"4487_CR6","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"K.M. Hoeger, A. Dokras, T. Piltonen, Update on PCOS: Consequences, Challenges, and guiding treatment. J. Clin. Endocrinol. Metab. 106(3), e1071\u2013e1083 (2021)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4487_CR7","first-page":"43","volume":"23","author":"M Pir\u00f3g","year":"2019","unstructured":"M. Pir\u00f3g et al., The thin red line - postmenopausal abnormal uterine bleeding with endometrial thickness less than 4\u00a0mm. Contemp. Oncol. (Pozn). 23(1), 43\u201346 (2019)","journal-title":"Contemp. Oncol. (Pozn)"},{"issue":"4","key":"4487_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s42000-024-00576-5","volume":"23","author":"A Theodorou","year":"2024","unstructured":"A. Theodorou et al., Female-specific risk factors for cardiovascular disease: an update. Horm. (Athens). 23(4), 637\u2013653 (2024)","journal-title":"Horm. (Athens)"},{"issue":"1","key":"4487_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ijgo.70160","volume":"171","author":"E. Zabieg\u0142o","year":"2025","unstructured":"E. Zabieg\u0142o, R. Jach, M. Pir\u00f3g, Age and BMI-related changes in hormonal profile in women with polycystic ovary syndrome (PCOS): association with infertility. Int. J. Gynaecol. Obstet. 171(1), 353-361 (2025)","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"4487_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s13679-020-00388-9","volume":"9","author":"E Kostopoulou","year":"2020","unstructured":"E. Kostopoulou et al., Polycystic ovary syndrome in adolescents: pitfalls in diagnosis and management. Curr. Obes. Rep. 9(3), 193\u2013203 (2020)","journal-title":"Curr. Obes. Rep."},{"key":"4487_CR11","doi-asserted-by":"publisher","first-page":"980405","DOI":"10.3389\/fendo.2022.980405","volume":"13","author":"C Long","year":"2022","unstructured":"C. Long et al., Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis. Front. Endocrinol. (Lausanne). 13, 980405 (2022)","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"4487_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40618-020-01351-0","volume":"44","author":"P Moghetti","year":"2021","unstructured":"P. Moghetti, F. Tosi, Insulin resistance and PCOS: chicken or egg? J. Endocrinol. Invest. 44(2), 233\u2013244 (2021)","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"4487_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpag.2014.03.002","volume":"28","author":"SE Powers","year":"2015","unstructured":"S.E. Powers et al., Trends in standard workup performed by pediatric subspecialists for the diagnosis of adolescent polycystic ovary syndrome. J. Pediatr. Adolesc. Gynecol. 28(1), 43\u201346 (2015)","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"6","key":"4487_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"E. Diamanti-Kandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33(6), 981\u20131030 (2012)","journal-title":"Endocr. Rev."},{"issue":"6","key":"4487_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/humrep\/dead053","volume":"38","author":"LJ Dobbie","year":"2023","unstructured":"L.J. Dobbie et al., Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis. Hum. Reprod. 38(6), 1168\u20131182 (2023)","journal-title":"Hum. Reprod."},{"issue":"5","key":"4487_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/pedi.13206","volume":"22","author":"J Hudnut-Beumler","year":"2021","unstructured":"J. Hudnut-Beumler et al., Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity. Pediatr. Diabetes. 22(5), 699\u2013706 (2021)","journal-title":"Pediatr. Diabetes"},{"issue":"2","key":"4487_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/humrep\/dew329","volume":"32","author":"MM Ollila","year":"2017","unstructured":"M.M. Ollila et al., Overweight and obese but not normal weight women with PCOS are at increased risk of type 2 diabetes mellitus-a prospective, population-based cohort study. Hum. Reprod. 32(2), 423\u2013431 (2017)","journal-title":"Hum. Reprod."},{"issue":"4","key":"4487_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.fertnstert.2013.12.050","volume":"101","author":"C Celik","year":"2014","unstructured":"C. Celik et al., Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study. Fertil. Steril. 101(4), 1123\u20138e1 (2014)","journal-title":"Fertil. Steril."},{"issue":"9","key":"4487_CR19","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/humrep\/dead156","volume":"38","author":"HJ Teede","year":"2023","unstructured":"H.J. Teede et al., Recommendations from the 2023 international Evidence-based guideline for the assessment and management of polycystic ovary Syndrome\u2020. Hum. Reprod. 38(9), 1655\u20131679 (2023)","journal-title":"Hum. Reprod."},{"issue":"5","key":"4487_CR20","doi-asserted-by":"publisher","first-page":"E841","DOI":"10.1210\/jc.2013-3918","volume":"99","author":"A Roe","year":"2014","unstructured":"A. Roe et al., Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS. J. Clin. Endocrinol. Metab. 99(5), E841\u2013E847 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4487_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s42000-023-00438-6","volume":"22","author":"L Zhang","year":"2023","unstructured":"L. Zhang et al., Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome. Horm. (Athens). 22(2), 263\u2013271 (2023)","journal-title":"Horm. (Athens)"},{"key":"4487_CR22","doi-asserted-by":"publisher","first-page":"1436952","DOI":"10.3389\/fendo.2024.1436952","volume":"15","author":"K Jakubowska-Kowal","year":"2024","unstructured":"K. Jakubowska-Kowal, K. Skrzy\u0144ska, A. Gawlik-Starzyk, Treatment and complications of PCOS in adolescents - what\u2019s new in 2023? Front. Endocrinol. (Lausanne). 15, 1436952 (2024)","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"4487_CR23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1210\/jc.2015-3543","volume":"101","author":"MM Ollila","year":"2016","unstructured":"M.M. Ollila et al., Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: prospective cohort study. J. Clin. Endocrinol. Metab. 101(2), 739\u2013747 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4487_CR24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"S.S. Lim et al., Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update. 18(6), 618\u2013637 (2012)","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"4487_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s12020-014-0340-9","volume":"48","author":"A Albu","year":"2015","unstructured":"A. Albu et al., Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients. Endocrine. 48(2), 696\u2013704 (2015)","journal-title":"Endocrine"},{"issue":"4","key":"4487_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"H.J. Teede et al., Recommendations from the 2023 international Evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 120(4), 767\u2013793 (2023)","journal-title":"Fertil. Steril."},{"issue":"6","key":"4487_CR27","doi-asserted-by":"publisher","first-page":"e99252","DOI":"10.1371\/journal.pone.0099252","volume":"9","author":"MJ Kim","year":"2014","unstructured":"M.J. Kim et al., Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea. PLoS One. 9(6), e99252 (2014)","journal-title":"PLoS One"},{"key":"4487_CR28","doi-asserted-by":"publisher","first-page":"35539","DOI":"10.1038\/srep35539","volume":"6","author":"MR Laurent","year":"2016","unstructured":"M.R. Laurent et al., Sex hormone-binding Globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis. Sci. Rep. 6, 35539 (2016)","journal-title":"Sci. Rep."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04487-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04487-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04487-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:51:24Z","timestamp":1768989084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04487-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4487"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04487-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee at Jagiellonian University Medical College approved the study (reference number KBET 1072.6120.316.2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}},{"value":"All participants provided informed, written consent in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}],"article-number":"41"}}